The COVID-19 pandemic highlighted and worsened underlying healthcare disparities in access, risks, and outcomes for specific population groups. These differences may also be caused by social factors such as transportation, nutrition, education, housing, and child care—called social determinants of health. Identify patient groups at risk using our extensive data and rely on our expert guidance to identify opportunities to address this societal issue.
The accuracy of the CMS-HCC model differs by beneficiaries’ race and ethnicity.
Lack of running water or indoor plumbing increases morbidity and mortality risk for vulnerable populations.
Among Medicare Fee-for-Service (FFS) beneficiaries, potential rare disease patients' residences have a median distance of over 200 miles to a relevant clinical trial site.
Increasing clinical trial diversity presents unique challenges for rare disease treatments due to population size, disease heterogeneity, and low awareness.
Avalere found that from 2016 to 2022, hospitals undergoing mergers and acquisitions were more likely to have 500+ beds and to be a 340B covered entity.
The Health Systems Transformation Research Coordinating Center aims to change how research is generated, funded, and used to transform health systems in promotion of broader health equity for Medicaid-eligible individuals.
Among LIS Medicare patients using oral/IV therapy for kidney cancer, social risk factors may impact adherence, even when the OOP burden is reduced.
Telehealth has the potential to expand access to healthcare by allowing people to interact with providers remotely, but disparities affect access to the technology that makes telehealth possible.
On November 4, Avalere presented a poster on disparities in wait times for kidney transplants at the American Society of Nephrology (ASN) Kidney Week 2022 conference.
Changes in clinical and social risk among Medicare beneficiaries treated in SNFs at the start of the pandemic reflect challenges facing the healthcare sector during a public health emergency.
Avalere found that characteristics of Medicare patients’ place of residence influenced adherence to combination treatment regimens for multiple myeloma.
Clinical trial participation has not appropriately represented all patient populations, which risks overlooking all patients’ perspectives and potential health outcomes. Numerous federal efforts have taken place this year to enhance equity in clinical trials, however, a lack of legislative progress leaves an opportunity for life science companies to get involved.
An Avalere analysis explores disparities in medication adherence for Medicare Part D beneficiaries living in medically underserved areas (MUAs) and non-MUAs.
Successful initiatives to address malnutrition and food insecurity through quality measurement and community partnerships are improving malnutrition care across the country and addressing health equity.
As policymakers continue to consider reforms to the Part D benefit design, an Avalere analysis finds that a disproportionate share of disabled beneficiaries and racial/ethnic minority groups, including Black and Hispanic beneficiaries, would have out-of-pocket (OOP) costs above $2,000 in 2024, indicating that an OOP spending cap under Part D benefit redesign may particularly benefit these patient populations.
As climate change continues to alter the patterns of everyday life, healthcare stakeholders should consider strategies to prevent and mitigate negative environmental contributions and proactively address the impacts of climate change on health outcomes, health equity, and healthcare costs.
Quality regulators are implementing new requirements and performance measures to expand health equity expectations for health plans. Avalere describes common approaches and identifies data-driven strategies to respond.
Avalere analysis seeks to understand potential access to clinical trial sites by race, given the draft requirement to ensure diverse participation.
Multiple health equity focused policy proposals are expected in 2022. Healthcare organizations should be primed to engage in comment periods and evaluate readiness for changes to quality measures.
Tune into the third episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In the final segment, our Market Access and Policy experts take a deeper dive into disparities in kidney care and discuss how various groups are looking to address these gaps.